SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 870.89 |
| Enterprise Value ($M) | 1,017.90 |
| Book Value ($M) | 145.68 |
| Book Value / Share | 0.61 |
| Price / Book | 5.98 |
| NCAV ($M) | 48.17 |
| NCAV / Share | 0.20 |
| Price / NCAV | 18.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.16 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.81 |
| Current Ratio | 4.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 312.69 |
| Assets | 410.19 |
| Liabilities | 264.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 333.62 |
| Operating Income | -27.95 |
| Net Income | -39.14 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -44.81 |
| Cash from Investing | -18.32 |
| Cash from Financing | 106.59 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 10.30 | ||
| 13G | State Street Corp | 4.90 | -3.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,493,095 | 6,180,879 | 24.16 | |
| 1,389,726 | 4,499,044 | 30.89 | |
| 1,914,569 | 8,184,076 | 23.39 | |
| 4,258,005 | 13,183,910 | 32.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLT – Applied Therapeutics, Inc. | AQST – Aquestive Therapeutics, Inc. |
| ARCT – Arcturus Therapeutics Holdings Inc. | ATAI – Atai Life Sciences N.V. |
| ATXS – Astria Therapeutics, Inc. |